NEXIMMUNE

NexImmune is an early stage biopharmaceutical company developing novel immuno-therapeutics based on the proprietary Artificial IMmune (AIMTM) technology. The AIM technology provides an important advance in the development of immunotherapies for a variety of cancers and other diseases. The AIM technology has been designed to orchestrate specific immune system responses in a highly controllable and reproducible way independent of the healthiness or abundance of the patient’s natural antigen presenting cell (APC) population. Natural APCs are major players in the body’s immune system as they direct the immune system cells in attacks on specifically targeted antigens and cells. However, under certain disease conditions, natural APCs can be damaged, absent or inactive.

#SimilarOrganizations #People #Financial #Event #Website #More

NEXIMMUNE

Social Links:

Industry:

Biopharma Biotechnology Therapeutics

Founded:

2011-01-01

Address:

Gaithersburg, Maryland, United States

Country:

United States

Website Url:

http://www.neximmune.com

Total Employee:

11+

Status:

Active

Contact:

3018610009

Email Addresses:

[email protected]

Total Funding:

210.27 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress

Similar Organizations

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

Current Advisors List

kenneth-carter_image

Kenneth Carter Chairman @ NexImmune
Board_member

Current Employees Featured

john-trainer_image

John Trainer
John Trainer Chief Financial Officer @ NexImmune
Chief Financial Officer

bob-knight_image

Bob Knight
Bob Knight Chief Medical Officer @ NexImmune
Chief Medical Officer

scott-carmer_image

Scott Carmer
Scott Carmer COO @ NexImmune
COO
2014-01-01

daniel-bednarik_image

Daniel Bednarik
Daniel Bednarik Executive Consultant @ NexImmune
Executive Consultant
2015-06-01

kristi-jones_image

Kristi Jones
Kristi Jones Chief Executive Officer @ NexImmune
Chief Executive Officer
2022-02-01

mathias-oelke_image

Mathias Oelke
Mathias Oelke Chief Scientific Officer @ NexImmune
Chief Scientific Officer
2022-04-01

Founder

jonathan-schneck_image

Jonathan Schneck

Stock Details

Company's stock symbol is NASDAQ:NEXI

Investors List

irving-investors_image

Key Employee Changes

Date	New article
2022-04-14	NexImmune Promotes Mathias Oelke, Ph.D., To Chief Scientific Officer
2022-02-17	NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors

Official Site Inspections

http://www.neximmune.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.36 K

Host Informations
Whois Informations

Loading ...